- Report
- October 2023
- 26 Pages
Global
€10992EUR$12,250USD£9,460GBP
- Report
- January 2023
- 50 Pages
United States
From €2692EUR$3,000USD£2,317GBP
- Report
- January 2023
- 25 Pages
Global
€10992EUR$12,250USD£9,460GBP
- Report
- May 2022
- 130 Pages
China
From €4486EUR$5,000USD£3,861GBP
- Report
- January 2022
- 230 Pages
Global
From €4127EUR$4,600USD£3,552GBP
- Drug Pipelines
- April 2021
- 78 Pages
Global
€19740EUR$22,000USD£16,990GBP
- Report
- February 2019
- 19 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €19740EUR$22,000USD£16,990GBP
- Report
- October 2018
- 17 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- October 2018
- 19 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- October 2018
- 20 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- October 2018
- 16 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- October 2018
- 17 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- July 2018
- 27 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- July 2018
- 14 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- June 2018
- 15 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- June 2018
- 11 Pages
Global
From €8973EUR$10,000USD£7,723GBP
- Report
- March 2018
United States
From €4033EUR$4,495USD£3,471GBP
- Report
- March 2018
United States
From €4033EUR$4,495USD£3,471GBP
- Report
- February 2018
- 15 Pages
Global
From €8973EUR$10,000USD£7,723GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more